SCHEMBL18749573

SCHEMBL18749573

CCC(=O)N(CC)c1ccccc1COc1ccc(C)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ FFAR4 Q5NUL3 6/20 0.41
▸ FFAR1 O14842 3/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18749330 0.90 MRGPRX4 (0.45) MRGPRX4MEN1KMT2AFFAR4FFAR1
SCHEMBL18514949 0.89 FFAR4 (0.47) FFAR4FFAR1ALDH1A1HSD17B10CD274
SCHEMBL18749585 0.87 MRGPRX4 (0.45) MRGPRX4MEN1KMT2AFFAR4FFAR1
SCHEMBL18749700 0.87 MRGPRX4 (0.45) MRGPRX4MEN1KMT2AFFAR4FFAR1
SCHEMBL18749337 0.86 MRGPRX4 (0.43) MRGPRX4MEN1KMT2AFFAR4FFAR1
SCHEMBL18749715 0.86 MRGPRX4 (0.43) MRGPRX4MEN1KMT2AFFAR4FFAR1
SCHEMBL18749414 0.85 MRGPRX4 (0.43) MRGPRX4MEN1KMT2AFFAR4L3MBTL1
SCHEMBL18749569 0.85 MRGPRX4 (0.46) MRGPRX4MEN1KMT2AFFAR4L3MBTL1
SCHEMBL18749481 0.83 MRGPRX4 (0.45) MRGPRX4MEN1KMT2AFFAR4L3MBTL1
SCHEMBL18749570 0.82 MRGPRX4 (0.44) MRGPRX4MEN1KMT2AFFAR4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 — — US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 — — US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 MRGPRX4 959/4885MEN1 1194/4885KMT2A 705/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 MRGPRX4 778/4885MEN1 2823/4885KMT2A 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback